Publication | Closed Access

Effects of bezafibrate on the serum lipoprotein lipid and apolipoprotein composition, lipoprotein triglyceride removal capacity and the fatty acid composition of the plasma lipid esters

ObesityMetabolic SyndromeLipid AnalysisCardiovascular DiseaseBiochemistryMedicinePhysiologyLipid DisordersLipoprotein MetabolismPlasma Lipid EstersSerum LipoproteinMetabolismPharmacologyApolipoprotein CompositionAtherosclerosisDyslipidemiaHealth Sciences